R&D Trends

Pfizer and Hisun to increase access to high-quality generics

Wednesday, February 22, 2012 02:00 PM

Pfizer and Zhejiang Hisun Pharmaceutical are establishing a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Global outGRID will centralize Alzheimer’s research online

Wednesday, February 22, 2012 01:56 PM

Europe’s neuGRID, a cloud-computing infrastructure that stores and analyses a vast database of 3D brain scans, is joining with Canada’s CBRAIN and the U.S.’s LONI to create outGRID, a global online system to centralize and boost Alzheimer’s research initiatives.

More... »


Enanta, Novartis collaborate to advance Hep C inhibitor

Wednesday, February 22, 2012 01:53 PM

Enanta Pharmaceuticals, a developer of best-in-class small molecule drugs in the infectious disease field, has formed an exclusive collaboration and license agreement with Novartis for the worldwide development, manufacture and commercialization of its lead development candidate, EDP-239, a hepatitis C virus inhibitor.

More... »

Faculty of 1000 to launch open access publishing venture

Friday, February 17, 2012 01:50 PM

Faculty of 1000 (F1000) is set to launch F1000 Research, a new fully open access publishing program across biology and medicine, later this year.

More... »

Complete Genomics to provide whole genome sequencing to Mayo Clinic

Friday, February 17, 2012 01:44 PM

Complete Genomics has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.

More... »

Evotec, IR Pharma partner for respiratory disease drug discovery

Friday, February 17, 2012 01:41 PM

Evotec and IR Pharma have formed an exclusive strategic alliance to provide integrated drug discovery solutions to pharmaceutical and biotech companies in the field of respiratory diseases.

More... »

Broad Institute joins Illumina Genome Network

Thursday, February 16, 2012 06:22 AM

The Broad Institute has joined the Illumina Genome Network (IGN) to offer its proprietary sample preparation processes for whole human genome sequencing.

More... »

Valeant to acquire Eyetech

Wednesday, February 15, 2012 03:45 PM

Valeant Pharmaceuticals International has agreed to acquire Eyetech, a privately-owned ophthalmic biotechnology company, for an undisclosed upfront payment and potential future milestones.

More... »

New Academy gives Irish researchers a voice in policy making

Tuesday, February 14, 2012 11:46 AM

The European Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn, has launched a new Academy to bring together Ireland's leading medical researchers to promote excellence in biomedical research, with the ultimate aim of improving the health of the population.

More... »

Pepscan achieves milestones from Janssen

Saturday, February 11, 2012 07:53 AM

Pepscan Therapeutics, a Netherlands-based biotechnology firm focusing on protein mimicry technology, has achieved two milestones in the research collaboration with Janssen R&D Ireland, formerly Tibotec Pharmaceuticals, and received undisclosed payments. 

More... »

`

CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs